New patent for Eli Lilly drug ZEPBOUND
Annual Drug Patent Expirations for ZEPBOUND Zepbound is a drug marketed by Eli Lilly And Co and is included in […]
Patent Added
New patent for Axsome drug AUVELITY
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It
New patent for Eli Lilly drug MOUNJARO
Annual Drug Patent Expirations for MOUNJARO Mounjaro is a drug marketed by Eli Lilly And Co and is included in
New patent for Ocuphire drug RYZUMVI
Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The
New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included
New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
New patent for Bausch drug JUBLIA
Annual Drug Patent Expirations for JUBLIA Jublia is a drug marketed by Bausch and is included in one NDA. It
New patent for Abbvie drug NAMZARIC
Annual Drug Patent Expirations for NAMZARIC Namzaric is a drug marketed by Abbvie and is included in one NDA. It
New patent for Axsome Malta drug SUNOSI
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA.
New patent for Intra-cellular drug CAPLYTA
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It
